Business & Industry

The biopharmaceutical sector is currently navigating an era of unprecedented growth and technological complexity. As the global drug pipeline shifts toward advanced modalities such as cell and gene therapies, bispecific antibodies, and complex mRNA formulations, the demands placed on...

The global pharmaceutical industry is currently facing a critical period of self reflection regarding the stability and reliability of its logistics networks. For years, the sector prioritized cost optimization and just in time manufacturing, leading to a highly centralized...

The integration of advanced technology into the clinical environment is fundamentally altering the relationship between patients, providers, and the pharmaceutical industry. For decades, the standard approach to healthcare was reactive, centralized, and episodic. Patients would visit a hospital or...

The pharmaceutical industry is currently witnessing a fundamental shift in how chronic conditions are managed, driven largely by the emergence of potent incretin therapies. While these treatments originally gained traction for their glucose lowering capabilities, the scope of their...

The German pharmaceutical group Merck KGaA announced that it has entered into a definitive agreement to purchase the United States-based biotechnology firm Bio-Techne for $11.3 billion. This transaction represents the largest deal for the Darmstadt-based organization in more than...

Novartis has finalized a significant collaboration agreement with Antares Therapeutics to advance the discovery and development of small molecule therapies for various cancers. The deal, which could reach a total value of $1.9 billion, focuses on addressing oncology targets...

The Department of Health – Abu Dhabi (DoH) has announced a strategic collaboration with MSD to evaluate the feasibility of establishing an Abu Dhabi logistics hub. Located within the Health, Endurance, Longevity, and Medicine (HELM) Cluster, this planned facility...